MedCity Update – March 2015
View this email in your browser

Welcome

From Sarah Haywood, Chief Operating Officer of MedCity

A stimulating visit to the US East Coast in February as part of the Mayor of London’s delegation has provided much food for thought for us here at MedCity. Despite heavy snow, we were able to make some useful new contacts and raise the profile of UK life sciences within the influential investor and industry communities of Boston and New York. An overriding impression for me was the level of investment available in the Cambridge-Boston area and the proactive involvement of investors themselves, who are not waiting for companies to pitch to them but are seeding companies themselves. You can see more news and feedback from our visit below.

MedCity and the Mayor promote UK life sciences 

Despite deep snow and temperatures that rarely made it above freezing, Boris Johnson and MedCity completed a successful week in the USA, with a programme of public and private events including meetings with key American investors, entrepreneurs and business leaders.
Read more about MedCity’s visit

Read Sarah Haywood’s blog for the BIA

Read Eliot Forster’s article for Boston’s Xconomy 

Angels in MedCity – coming up

Free Angels in MedCity workshops and pitching events are continuing throughout 2015. Book to attend an investor workshop and find out how to apply to pitch to the new community of life sciences angels here.
Read more about Angels in MedCity

US companies announce major London healthcare investment

US companies Gilead Sciences and Mobiquity announced significant new investment in London to coincide with Boris Johnson’s US delegation. Gilead is creating a new commercial HQ in London alongside expansion of its Uxbridge and Cambridge sites in a move that will double its UK workforce and see an increased investment of $19.6m.
Boston-based Mobiquity, a mobile technology company attracted by London’s digital health strengths, is basing its $20m European HQ in the capital, where its first partners will include Pfizer.
Read more

First Pfizer Rare Disease Consortium projects announced

Pfizer and the University of Oxford have announced a new research collaboration focusing on haematology and neuromuscular disorders. The project is part of a strategic alliance to develop new treatments for rare disorders that brings together Pfizer with Oxford, Cambridge, Imperial College London, University College London, King’s College London and Queen Mary University of London.
Read more

Major dementia investment announced 

£300m will be invested to create an international dementia research institute in the UK, Prime Minister David Cameron has announced as part of a raft of initiatives to make the UK more dementia-friendly. At the same time, NHS England and the Department of Health have launched Join Dementia Research, a ‘matchmaker scheme’ for clinical research. 

Read more

Dementia Investment Forum

OneNucleus is holding a free Dementia Investment Forum on Wednesday 15 April with sessions on opportunities and challenges in both technology and therapeutics for dementia, plus how public-private partnerships can change the dynamic. The one day event takes place at the Queen Mary Innovation Centre and is supported by Hume Brophy.

Register here

MedCity discounts at WIRED Health 

Meet MedCity at WIRED Health on 24 April, when we will be hosting a space within the networking area. The event, which takes place at the Royal College of General Practitioners, is offering a 50% discount for SMEs. Other members of the MedCity community can get a 10% discount by using the code WHMEDC15 when you book.

Book here

Imperial expands to Babraham

Imperial is investing in a new facility at the Babraham Research Campus in Cambridge that will provide high quality lab and office workspaces for spin-out and scale-up companies.  Its first tenant will be Abzena, a biopharmaceutical company that already has over 90 staff on the campus. 

Read more

King’s PhD student wins £10,000 for NeoMate app

A smartphone app developed by a King’s College London PhD student has been awarded £10,000 after winning an NHS Innovation Challenge Prize. The NeoMate app provides instant decision support for junior doctors and nurses caring for very sick babies. It is free to download and there are plans for a national roll-out. 

Read more 

Data saves lives campaign

An alliance bringing together a range of research organisations including the Wellcome Trust and Cancer Research UK has launched a campaign to ensure that data protection regulation does not limit the use of personal data in medical research. 

Find out more about the campaign
Support the campaign on Twitter @DataMattersEU

Coming up

BioTrinity, OBN
BIA Networking Evening – Oxford, BioIndustry Association

Developing London’s Tech Sector, Policy Forum for London
London Regenerative Medicine Networking Event, LRMN
Anglonordic Life Science Conference XII, BioPartner UK
Great Week Healthcare and Life Sciences – World Expo 2015, UK Trade & Investment

 

Email us to share your event

MedCity was established in April 2014 by the Mayor of London with the capital’s three Academic Health Science Centres – Imperial College Academic Health Centre, King’s Health Partners and UCLPartners.

MedCity
2 Royal College Street
London NW1 0NH
T: 020 7691 3588
E: contact@medcitylondon.com 

The next edition of MedCity Update will be sent in April 2015.

Twitter
Twitter

Website
Website

Copyright © 2014 MedCity. All rights reserved.